Meteora Capital’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.82M Buy
919,000
+662,746
+259% +$7.08M 0.81% 39
2026
Q1
$2.71M Sell
256,254
-14,589
-5% -$154K 0.2% 113
2025
Q4
$2.83M Buy
+270,843
New +$2.82M 0.24% 94

Other funds holding TDAC

Meteora Capital's TDAC Position: Q2 2026 in Review

Meteora Capital increased its Translational Development Acquisition Corp (TDAC) stake by 259% in Q2 2026, buying an estimated $7.08M and bringing the position to 919,000 shares worth $9.82M. The position accounts for 0.81% of the portfolio, ranked #39.

Meteora Capital first reported a position in TDAC in Q4 2025 and has held it in 3 quarters since. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • Meteora Capital held 919,000 shares of Translational Development Acquisition Corp worth $9.82M as of Q2 2026.
  • Meteora Capital bought 662,746 Translational Development Acquisition Corp shares in Q2 2026, an estimated $7.08M.
  • Translational Development Acquisition Corp made up 0.81% of Meteora Capital's portfolio in Q2 2026, its #39 holding.
  • Meteora Capital first reported a position in Translational Development Acquisition Corp in Q4 2025 and has held it in 3 quarters since.
  • 35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Meteora Capital's 13F filing for Q2 2026, filed 14 Aug 2026.